(Q35946085)

11 August 2017

1 reference

title

Aldose reductase inhibition in the treatment of diabetic neuropathy: where are we in 2004? (English)

1 reference

11 August 2017

1 reference

Kenneth H Gabbay

1

1 reference

11 August 2017

publication date

1 December 2004

1 reference

11 August 2017

published in

Current diabetes report

1 reference

11 August 2017

volume

4

1 reference

11 August 2017

issue

6

1 reference

11 August 2017

page(s)

405-408

1 reference

Aldose reductase inhibitors: the end of an era or the need for different trial designs?

11 August 2017

cites work

1 reference

Crossref

https://api.crossref.org/works/10.1007%2FS11892-004-0047-Z

Purification and immunologic identification of aldose reductases

21 January 2018

1 reference

Crossref

https://api.crossref.org/works/10.1007%2FS11892-004-0047-Z

Glomerular changes in diabetes mellitus

21 January 2018

1 reference

12 December 2020

Aldose reductase inhibition by AS-3201 in sural nerve from patients with diabetic sensorimotor polyneuropathy

1 reference

12 December 2020

Validation of the Toronto Clinical Scoring System for diabetic polyneuropathy

1 reference

12 December 2020

Reduction of glomerular hyperfiltration in normoalbuminuric IDDM patients by 6 mo of aldose reductase inhibition.

1 reference

12 December 2020

Clinical Trials of Diabetic Neuropathy: Past, Present, and Future

1 reference

12 December 2020

Increased vascular permeability in spontaneously diabetic BB/W rats and in rats with mild versus severe streptozocin-induced diabetes. Prevention by aldose reductase inhibitors and castration

1 reference

12 December 2020

Crucial role of aldose reductase activity and plasma glucose level in sorbitol accumulation in erythrocytes from diabetic patients.

1 reference

12 December 2020

Effect of intensive diabetes treatment on nerve conduction in the Diabetes Control and Complications Trial

1 reference

12 December 2020

Aldose reductase activation is a key component of myocardial response to ischemia

1 reference

12 December 2020

Cardiac abnormalities in diabetic patients with neuropathy: effects of aldose reductase inhibitor administration

1 reference

12 December 2020

Association of erythrocyte aldose reductase activity with diabetic complications in type 1 diabetes mellitus

1 reference

12 December 2020

No correlation between glycemic control and an increase in erythrocyte aldose reductase activity in type I and type II diabetic patients

1 reference

12 December 2020

The effect of blood pressure intervention on renal function in insulin-dependent diabetes

1 reference

12 December 2020

A thirty year journey in the polyol pathway

1 reference

12 December 2020

Role of sorbitol pathway in neuropathy

1 reference

12 December 2020

Clinical efficacy of fidarestat, a novel aldose reductase inhibitor, for diabetic peripheral neuropathy: a 52-week multicenter placebo-controlled double-blind parallel group study

1 reference

12 December 2020

Aldose reductase inhibition improves nerve conduction velocity in diabetic patients

1 reference

12 December 2020

Diabetic neuropathy: a review emphasizing diagnostic methods

1 reference

12 December 2020

Aldose reductase in retinal mural cells

1 reference

12 December 2020

Enzyme immunoassay for erythrocyte aldose reductase

1 reference

12 December 2020

Quantitative determination of human aldose reductase by enzyme-linked immunosorbent assay. Immunoassay of human aldose reductase

1 reference

12 December 2020

Diabetic-like retinopathy in rats prevented with an aldose reductase inhibitor

1 reference

12 December 2020

Aldose reductase inhibition protects diabetic and nondiabetic rat hearts from ischemic injury

1 reference

12 December 2020

10.1007/S11892-004-0047-Z

Identifiers

DOI

1 reference

release_ze74qssiafe2zb4b6vl4gdlxqm

11 August 2017

Fatcat ID

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/ze74qssiafe2zb4b6vl4gdlxqm

24 November 2022

mapped directly with Wikidata item

1 reference